Q: Today, Cardiome jumped 8% in a down market based on receiving approval from Health Canada to market Brinavess and seem to have had a solid Q1 with Aggrastat. New product commercialization and launches are scheduled for next month and seem to have momentum. Can I have your assessment? Thank you for your support.
Marty
Marty